The Indian CDMO market is expected to capture 4-5% of global demand by 2028, doubling from $7 billion to $14 billion. This unprecedented growth has been characterized by an increasing demand for specialized chemicals, pharmaceuticals, and customized formulations.

However, businesses have become more particular about who they work with, often seeking deep technical expertise, flexibility, and end-to-end support. This is why we follow an R&D first approach at Scimplify to streamline contract development and manufacturing.

Our expertise in custom synthesis of different molecules, efficient process development, and scale-up manufacturing for the pharmaceutical, agrochemical, and other industries has helped us become a trusted CDMO partner of more than 150+ businesses globally.

Why Should You Choose Scimplify as Your CDMO Partner?

Scimplify’s R&D team of 30+ scientists led by Dr. Ravi Ponniah and Dr. Javed Iqbal brings a wide range of expertise in broad chemistries to handle various reactions and niche chemistries. We also use the latest lab equipment and technologies like electronic databanks and notebooks for data security in our labs to protect client data.

1. Comprehensive Industry Expertise

Scimplify’s diverse portfolio ensures that we can meet the specific needs of various sectors, delivering tailored solutions that drive success. Unlike traditional CDMOs focusing on limited capabilities, we integrate R&D, manufacturing, and commercialization to ensure end-to-end support.

Pharmaceuticals: We enable R&D for life-saving discoveries and optimize drug formulations to address the industry’s gap in novel drug development and process innovation. Our expertise in complex chemistries, first-time scale-ups, and regulatory compliance positions us as a trusted leader.

Agrochemicals: Our team is transforming the agrochemical sector by developing sustainable and efficient formulations. We mitigate environmental impact with advanced process development and green chemistry methodologies while enhancing global supply chain resilience.
Flavors & Fragrances: We blend scientific expertise with creative innovations, we craft high-purity specialty molecules that meet global regulatory and safety standards, closing gaps in scalability and process consistency.
Industrial Chemicals: By addressing the fragmented supply chain dependency, our team manufactures and delivers specialty-grade chemicals for coatings, polymers, paints, dyes, and resins, ensuring steady global supply and compliance.
Beauty & Personal Care: We are advancing high-efficacy formulations with cutting-edge R&D, ensuring that each product delivers transformative performance and sensory appeal while meeting evolving regulatory and sustainability standards.
Food & Nutrition: Our focus on regulatory compliance, clean-label ingredients, and functional formulations helps us drive innovation in sustainable food solutions while bridging quality and safety gaps in ingredient sourcing.

2. End-to-End Process Development & Scale-Up

We provide comprehensive support from preclinical studies to commercial production, ensuring seamless tech transfer, cost efficiency, and process robustness. Traditional CDMOs struggle with scalability, multi-site consistency, and regulatory approvals—Scimplify solves these challenges by integrating:

Advanced computational modeling, retrosynthetic analysis, and kinetic profiling to design more efficient, high-yield synthetic routes with lower impurity profiles.
A multi-site manufacturing strategy to eliminate single-source dependency, ensuring supply chain continuity and process replication across multiple locations for zero variability and faster time to market.
A dedicated innovation team led by Dr. Ravi Ponniah and Dr. Javed Iqbal at the Scimplify Centre for Innovation (SCI), tackling complex chemistry challenges with next-gen process optimization and green synthesis techniques.
Multi-purpose reactors with stainless steel and glass-lined reactors (20L to 2000L) for batch and continuous processes, capable of high-pressure, cryogenic, and high-temperature reactions.

3. Advanced Reaction Capabilities

Scimplify provides 25+ reaction capabilities, enabling customers to access high-value, complex chemistries under GMP conditions. Some of our key capabilities include:

Friedel-Crafts Reaction: Synthesizing aromatic hydrocarbons, ketones, and other derivatives for applications in the pharmaceutical, agrochemical, and polymer industries.
Suzuki Couplings: Facilitating the formation of carbon-carbon bonds essential for synthesizing complex organic molecules.
Halogenation & Fluorination: Creating highly functionalized compounds for applications with the introduction of halogens in organic molecules.
Grignard Reaction: Using Grignard reagents that are organomagnesium compounds for synthesizing agrochemicals and fragrances.
Biocatalysis: Harnessing the power of enzymes or microorganisms to catalyze chemical reactions, enabling the efficient and sustainable synthesis of complex molecules.

4. Specialized Synthesis Suites

Scimplify’s facilities are designed to handle diverse chemical syntheses across scales, from milligrams to multi-ton quantities. Our infrastructure includes:

Potent Compound Labs: Isolated containment (OEB 4/5) with HEPA filtration for handling APIs and hazardous intermediates.
Catalytic & Biocatalytic Systems: Hydrogenation suites, enzymatic reactors, and chiral resolution technologies for stereoselective synthesis.
Peptide & Oligonucleotide Synthesis: Automated solid-phase synthesizers and HPLC purification systems.
Sustainability-Driven Practices: Solvent recovery systems, green chemistry protocols, and waste minimization strategies aligned with global ESG goals.

5. Regulatory & Quality Compliance

Regulatory challenges remain a significant hurdle for many CDMOs. Scimplify proactively addresses global compliance gaps by ensuring:

GMP-certified manufacturing that meets FDA, FMDA, EU GMP, and FSSAI standards, ensuring quality assurance at every production stage.
HPLC, UPLC, GC, NMR (400-600 MHz), and LC-MS for impurity profiling and structural elucidation.
IND, NDA, and CMC support for global submissions.
Regulatory documentation support for DMFs, REACH registration, and technical dossiers facilitates seamless global submissions and reduces approval delays.
End-to-end traceability and digitalized quality control, eliminating manual-heavy operations and reducing regulatory risks.

6. Commitment to Sustainability

As sustainability becomes a critical gap in the CDMO sector, Scimplify takes a proactive stance by implementing the following:

Eco-friendly manufacturing—optimizing reaction conditions to minimize waste and reduce carbon footprint.
Green chemistry and solvent recovery—adopting methodologies that ensure resource efficiency and regulatory compliance.
Advanced digitization and automation to enhance process sustainability while ensuring operational transparency.
Sustainable sourcing—eliminating reliance on environmentally hazardous raw materials through alternative green-sourced inputs.

End-to-End CDMO Process at Scimplify

At Scimplify, we drive end-to-end development and manufacturing of specialty chemicals by integrating cutting-edge R&D, scalable production, and regulatory expertise. From lead optimization to commercial manufacturing, we ensure efficiency, compliance, and quality at every stage, helping pharmaceutical innovators accelerate their journey from discovery to market.

1. Customer Collaboration & Process Feasibility Study

Our every project begins with a customer consultation to define goals, technical requirements, and regulatory expectations. Depending on the project, customers may provide an existing process, or our R&D team will develop a new synthesis route. Before proceeding, we conduct a feasibility study, evaluating raw material availability, cost efficiency, and potential scale-up challenges.

2. Research, Development & Proof of Concept

If process development is required, our R&D team designs and optimizes a synthetic pathway to ensure high efficiency, yield, and purity. A small-scale proof-of-concept batch is produced and tested for stability, impurity profiling, and compliance with industry standards. Regular milestone checks and progress updates are shared with the customer to align expectations.

Once the proof-of-concept batch meets the required specifications, we move to pilot-scale production, refining reaction conditions, purification methods, and impurity control strategies. Customers receive detailed progress reports, including batch data, safety studies, and process optimization insights, ensuring smooth scalability to commercial production.

4. Process Development & Scale-up For Commercialization

For successful commercialization, we optimize the manufacturing process to enhance cost efficiency, sustainability, and operational feasibility. Scimplify ensures the process is robust, reproducible, and compliant with global regulatory standards. We conduct risk assessments, impurity fate studies, and process validation trials to ensure seamless industrial-scale deployment.

5. Regulatory compliance & documentation

We ensure compliance with FDA, REACH, FSSAI, and other global authorities for regulated industries like pharmaceuticals, agrochemicals, and personal care. Our team prepares regulatory dossiers, safety data, and stability studies, ensuring alignment with industry expectations. Customers receive comprehensive documentation to support their filings and audits.

6. Validation, testing & pre-approval inspections

Before moving to large-scale production, we conduct validation batches to confirm process reproducibility, quality consistency, and compliance with customer and regulatory standards. Pre-approval inspections are coordinated with regulatory agencies and customer auditors to verify batch documentation, GMP protocols, and safety standards.

7. Commercial manufacturing & continuous monitoring

With regulatory approvals, Scimplify transitions to full-scale commercial production, ensuring a reliable supply chain, consistent product quality, and cost efficiency. Customers receive regular production updates, ongoing quality reports, and post-market stability data, ensuring transparency and long-term partnership success.

Conclusion

At Scimplify, we pride ourselves on being more than just a CDMO; we are your R&D-first manufacturing partner. Our expertise spans from innovative research to scalable, high-quality production tailored to your needs. Partner with us to unlock new opportunities. Write to us at info@scimplify.com to learn more about how we can support your goals.

Why Scimplify is Your Ideal CDMO Partner?